Literature DB >> 4685088

Maturation of the human complement system. I. Onset time and sites of fetal C1q, C4, C3, and C5 synthesis.

P F Kohler.   

Abstract

The onset times and sites of human C1q, C4, C3, and C5 synthesis were determined by culturing tissues from 23 fetuses, 8-25 wk old, in the presence of [(14)C]lysine and isoleucine. In parallel, IgG and IgM production was followed. Liver, spleen, placenta, peritoneal and bone marrow cells, thymus, and colon were cultured for 48 h and the concentrated media studied by immunoelectrophoresis and subsequent autoradiography using adult human serum as carrier and specific antisera. The quantitative synthesis was approximated by scoring the intensity of the labeled precipitin lines using uniform conditions. C5 production was detected earliest at 8 wk gestation and by 11 wk and thereafter, C3, C4, and C5 synthesis was uniformly present in multiple tissues. C1q synthesis, however, was limited almost exclusively to the spleen, began at 14 wk, and was not uniformly present. In contrast IgG and IgM production did not occur in three fetuses synthesizing complement and while detected as early as 11 wk. was inconstant, occurred predominantly in the spleen, and was quantitatively much less compared to C3, C4, and C5. These findings suggest that developmentally the complement system is a more primative biological defense mechanism than antibody.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4685088      PMCID: PMC302305          DOI: 10.1172/JCI107228

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  Beta-1C and immune globulin formation in vitro by tissues from germ-free and conventional rodents of various ages.

Authors:  V J Stecher; G J Thorbecke
Journal:  Immunology       Date:  1967-04       Impact factor: 7.397

2.  Sites of production of primate serum proteins associated with complement system.

Authors:  V J Stecher; J H Morse; G J Thorbecke
Journal:  Proc Soc Exp Biol Med       Date:  1967-02

3.  Studies on the serum proteins of chimeras. 3. Detection of donor-type C'5 in allogeneic and congenic post-irradiation chimeras.

Authors:  M E Phillips; U A Rother; K O Rother; G J Thorbecke
Journal:  Immunology       Date:  1969-08       Impact factor: 7.397

4.  Ontogenesis of two components of human complement: beta1E and beta1C-1A globulins.

Authors:  M Adinolfi; B Gardner; C B Wood
Journal:  Nature       Date:  1968-07-13       Impact factor: 49.962

5.  Complement-immunoglobulin relation: deficiency of C'1q associated with impaired immunoglobulin G synthesis.

Authors:  P F Kohler; H J Müller-Eberhard
Journal:  Science       Date:  1969-01-31       Impact factor: 47.728

6.  Development of human complement system.

Authors:  P Fireman; D A Zuchowski; P M Taylor
Journal:  J Immunol       Date:  1969-07       Impact factor: 5.422

7.  Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement.

Authors:  R J Pickering; M R Wolfson; R A Good; H Gewurz
Journal:  Proc Natl Acad Sci U S A       Date:  1969-02       Impact factor: 11.205

8.  Development of gamma G, gamma A, gamma M, beta IC-beta IA, C 1 esterase inhibitor, ceruloplasmin, transferrin, hemopexin, haptoglobin, fibrinogen, plasminogen, alpha 1-antitrypsin, orosomucoid, beta-lipoprotein, alpha 2-macroglobulin, and prealbumin in the human conceptus.

Authors:  D Gitlin; A Biasucci
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

9.  C3 leukotactic factors produced by a tissue protease.

Authors:  J H Hill; P A Ward
Journal:  J Exp Med       Date:  1969-09-01       Impact factor: 14.307

10.  Synthesis of the first component of human complement in vitro.

Authors:  H R Colten; J M Gordon; T Borsos; H J Rapp
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

View more
  10 in total

1.  Human complement C7 and C9 in fetal and newborn sera.

Authors:  M Adinolfi; S E Beck
Journal:  Arch Dis Child       Date:  1975-07       Impact factor: 3.791

2.  Evidence for complement activation in the amniotic fluid of women with spontaneous preterm labor and intra-amniotic infection.

Authors:  Eleazar Soto; Roberto Romero; Karina Richani; Bo H Yoon; Tinnakorn Chaiworapongsa; Edi Vaisbuch; Pooja Mittal; Offer Erez; Francesca Gotsch; Moshe Mazor; Juan P Kusanovic
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11

3.  Inflammatory mechanisms in the newborn.

Authors:  C J Dunn
Journal:  Agents Actions       Date:  1976-02

4.  Ontogeny of the third component of complement of Japanese quails.

Authors:  C Kai; Y Yoshikawa; K Yamanouchi; H Okada; S Morikawa
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

5.  Fragment Bb in amniotic fluid: evidence for complement activation by the alternative pathway in women with intra-amniotic infection/inflammation.

Authors:  Edi Vaisbuch; Roberto Romero; Offer Erez; Shali Mazaki-Tovi; Juan Pedro Kusanovic; Kusanovic Juan Pedro; Eleazar Soto; Francesca Gotsch; Zhong Dong; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Pooja Mittal; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-10

6.  Chemotactic and random movement of human newborn monocytes.

Authors:  L Maródi; S Csorba; B Nagy
Journal:  Eur J Pediatr       Date:  1980-10       Impact factor: 3.183

7.  Biosynthesis of normal and low-molecular-mass complement component C1q by cultured human monocytes and macrophages.

Authors:  R Hoekzema; M C Brouwer; E R de Graeff-Meeder; H P van Helden; C E Hack
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

8.  The first component of complement. A quantitative comparison of its biosynthesis in culture by human epithelial and mesenchymal cells.

Authors:  K M Morris; H R Colten; D H Bing
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

9.  Development of the immune system.

Authors:  A Durandy
Journal:  Infect Dis Obstet Gynecol       Date:  1997

Review 10.  Dysregulated Mucosal Immunity and Associated Pathogeneses in Preterm Neonates.

Authors:  Maame Efua S Sampah; David J Hackam
Journal:  Front Immunol       Date:  2020-05-15       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.